Cargando…
Fatty Acids: A Safe Tool for Improving Neurodevelopmental Alterations in Down Syndrome?
The triplication of chromosome 21 causes Down syndrome (DS), a genetic disorder that is characterized by intellectual disability (ID). The causes of ID start in utero, leading to impairments in neurogenesis, and continue into infancy, leading to impairments in dendritogenesis, spinogenesis, and conn...
Autores principales: | Martínez-Cué, Carmen, Bartesaghi, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323400/ https://www.ncbi.nlm.nih.gov/pubmed/35889838 http://dx.doi.org/10.3390/nu14142880 |
Ejemplares similares
-
Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
por: Rueda, Noemí, et al.
Publicado: (2012) -
Targeting APP/AICD in Down syndrome
por: Guidi, Sandra, et al.
Publicado: (2017) -
Antioxidants in Down Syndrome: From Preclinical Studies to Clinical Trials
por: Rueda Revilla, Noemí, et al.
Publicado: (2020) -
Signalling Pathways Implicated in Alzheimer′s Disease Neurodegeneration in Individuals with and without Down Syndrome
por: Martínez-Cué, Carmen, et al.
Publicado: (2020) -
The Challenging Pathway of Treatment for Neurogenesis Impairment in Down Syndrome: Achievements and Perspectives
por: Stagni, Fiorenza, et al.
Publicado: (2022)